Last reviewed · How we verify

NCT06245577: BioSynIRS

Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP

Active, enrolled NA Last updated 18 November 2024
What this trial tests

NA trial testing interdisciplinary mesh sacro colpopexy with resection rectopexy in Intestinal Obstruction in 30 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
30 January 2024
Primary endpoint
31 October 2024
31 December 2025

Quick facts

Lead sponsorEvangelisches Klinikum Köln Weyertal gGmbH
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date30 January 2024
Primary completion31 October 2024
Estimated completion31 December 2025
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Evangelisches Klinikum Köln Weyertal gGmbH

Who can join

Adults 18 to 80, female only, with Intestinal Obstruction or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the pilot study is to demonstrate the safety and efficacy of a biological mesh compared to a standard synthetic mesh for the planned procedure in the above-mentioned clinical picture. Subsequently, a multicentre, randomized intervention study is planned to confirm the results and evaluate the long-term outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intestinal Obstruction

Currently open trials in the same condition.

Other Evangelisches Klinikum Köln Weyertal gGmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06245577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing